IRIS Accounts Production v24.1.0.578 10459173 director 1.12.22 30.11.23 30.11.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104591732022-11-30104591732023-11-30104591732022-12-012023-11-30104591732021-11-30104591732021-12-012022-11-30104591732022-11-3010459173ns15:EnglandWales2022-12-012023-11-3010459173ns14:PoundSterling2022-12-012023-11-3010459173ns10:Director12022-12-012023-11-3010459173ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3010459173ns10:SmallEntities2022-12-012023-11-3010459173ns10:AuditExemptWithAccountantsReport2022-12-012023-11-3010459173ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3010459173ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3010459173ns10:FullAccounts2022-12-012023-11-3010459173ns10:RegisteredOffice2022-12-012023-11-3010459173ns5:CurrentFinancialInstruments2023-11-3010459173ns5:CurrentFinancialInstruments2022-11-3010459173ns5:ShareCapital2023-11-3010459173ns5:ShareCapital2022-11-3010459173ns5:RetainedEarningsAccumulatedLosses2023-11-3010459173ns5:RetainedEarningsAccumulatedLosses2022-11-3010459173ns5:FurnitureFittings2022-12-012023-11-3010459173ns5:FurnitureFittings2023-11-3010459173ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-11-3010459173ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-30
REGISTERED NUMBER: 10459173 (England and Wales)















SSPHARMA LTD

Unaudited Financial Statements for the Year Ended 30 November 2023






SSPHARMA LTD (REGISTERED NUMBER: 10459173)

Contents of the Financial Statements
for the Year Ended 30 November 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 5

SSPHARMA LTD

Company Information
for the Year Ended 30 November 2023







DIRECTOR: S S Gill





REGISTERED OFFICE: 31 Kingsway Road
Wolverhampton
WV10 0SR





REGISTERED NUMBER: 10459173 (England and Wales)





ACCOUNTANTS: Lancaster Haskins Limited
Granville House
2 Tettenhall Road
Wolverhampton
West Midlands
WV1 4SB

SSPHARMA LTD (REGISTERED NUMBER: 10459173)

Balance Sheet
30 November 2023

30.11.23 30.11.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,000 -

CURRENT ASSETS
Debtors 5 20,554 18,881
Cash at bank 15,494 8,001
36,048 26,882
CREDITORS
Amounts falling due within one year 6 36,552 26,677
NET CURRENT (LIABILITIES)/ASSETS (504 ) 205
TOTAL ASSETS LESS CURRENT
LIABILITIES

496

205

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 396 105
SHAREHOLDERS' FUNDS 496 205

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 August 2024 and were signed by:





S S Gill - Director


SSPHARMA LTD (REGISTERED NUMBER: 10459173)

Notes to the Financial Statements
for the Year Ended 30 November 2023


1. STATUTORY INFORMATION

SSPharma Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

SSPHARMA LTD (REGISTERED NUMBER: 10459173)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2023


4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
Additions 1,000
At 30 November 2023 1,000
NET BOOK VALUE
At 30 November 2023 1,000

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£    £   
Trade debtors 6,208 5,554
Other debtors 14,346 13,327
20,554 18,881

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£    £   
Tax 33,298 23,843
Accrued expenses 3,254 2,834
36,552 26,677

7. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is S S Gill.

8. GOING CONCERN

The director has considered the period ending 12 months after approving these financial statements and is prepared to fully support the company financially.. For this reason the director continues to adopt the going concern basis of accounting in preparing these financial statements

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
SSPharma Ltd


The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of SSPharma Ltd for the year ended 30 November 2023 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of SSPharma Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of SSPharma Ltd and state those matters that we have agreed to state to the director of SSPharma Ltd in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than SSPharma Ltd and its director for our work or for this report.

It is your duty to ensure that SSPharma Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of SSPharma Ltd. You consider that SSPharma Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of SSPharma Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Lancaster Haskins Limited
Granville House
2 Tettenhall Road
Wolverhampton
West Midlands
WV1 4SB


15 August 2024